Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2026-06-09 20:32:55 ET · period of report 2026-06-08 · accession 0001493152-26-028022 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-06-09 20:32 | 2026-06-08+ | ABEO | Vazzano Joseph Walter | CFO | S - Sale | $5.38 | -49.3K | 518.4K | -9% | -$265.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-08 | S | D | 10,271 | $5.43 | 557,504 | D | — | — | (F1) The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.345 to $5.54 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2026-06-09 | S | D | 13,421 | $5.30 | 544,083 | D | — | — | (F1) The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards. (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.24 to $5.47 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Common | Common Stock | 2026-06-09 | S | D | 25,646 | $5.39 | 518,437 | D | — | — | (F4) The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 21, 2026. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.30 to $5.42 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |